Although use of corticosteroid premedication prior to infliximab infusions is declining, it remains unnecessarily high despite limited benefit and the risk of serious adverse events from ...
Remicade (infliximab) is a prescription drug that’s used to manage certain autoimmune conditions in adults and some children. The drug is usually given as an intravenous (IV) infusion every 8 weeks.
Therapeutic persistence with infliximab was associated with signifi cantly fewer ulcerative colitis patients requiring hospitalization; once hospitalized, patients with therapeutic persistence had ...
Remicade (infliximab) is a brand-name drug that’s prescribed for certain autoimmune conditions. Remicade comes as an IV infusion that’s given by a healthcare professional. The dosage can vary ...
Enbrel (etanercept) and Remicade (infliximab) are prescription drugs used to manage certain autoimmune conditions. Enbrel is given as a subcutaneous injection, and Remicade is given as an IV infusion.
LAS VEGAS, Nev., October 23, 2006 -- Patients with ulcerative colitis (UC) treated with REMICADE® (infliximab) had an approximate 50 percent reduction in mean number of hospitalizations per year ...
Please provide your email address to receive an email when new articles are posted on . While serologic protection was achieved in only a relatively low proportion of IBD patients on Remicade ...
A BMJ study of 624,713 Swedish births linked HPV vaccination before pregnancy to 15% lower odds of very preterm birth. What families should know. Ozempic and Zepbound Makers Report Slower Aging Clocks ...
Birmingham, UK - Although infliximab (Remicade, Centocor) was licensed for use in the treatment of ankylosing spondylitis (AS) in Europe nearly 2 years ago, in the UK there has been little experience ...
Safety outcomes of intravenous immunoglobulin (IVIG) in treatment of steroid-refractory immune-checkpoint inhibitor pneumonitis. A phase 1, first-in-human study of DS-2243, an HLA-A*02/NY-ESO–directed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results